Drug intelligence / Profile preview

Cat epithelial allergenic extract (Laboratorios Leti)

Development stage
Unknown
Lead developer
Leti Pharma
Administration
Percutaneous, Subcutaneous
01

Overview

Cat epithelial allergenic extract (Laboratorios Leti) refers to a range of biological preparations derived from cat epithelium used for the diagnosis and treatment of cat allergy. These extracts contain major and minor allergens, most notably Fel d 1, along with Fel d 2, Fel d 3, Fel d 4, and Fel d 7. Laboratorios Leti has developed specific formulations including native, depigmented, and depigmented polymerized (allergoid) extracts. The depigmented polymerized version is manufactured through a process involving mild acid treatment followed by glutaraldehyde polymerization, which reduces its allergenicity (IgE binding) while maintaining its immunogenicity. In diagnostic skin prick tests, these extracts are used to confirm sensitization by triggering a localized wheal-and-flare reaction through IgE-mediated mast cell degranulation. Therapeutically, they are used in subcutaneous allergen immunotherapy (SCIT) to induce immunological tolerance in patients with allergic rhinitis, rhinoconjunctivitis, or asthma.

Other names
Cat epithelium allergenic extractNative cat epithelial extractDepigmented cat epithelial extractDepigmented polymerized cat epithelial extractCat allergoid
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Cat epithelial allergenic extract (Laboratorios Leti).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cat epithelial allergenic extract (Laboratorios Leti).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call